FINWIRES · TerminalLIVE
FINWIRES

Risk Appetite "On the Run" As Middle East Tensions Flare Again, Says Scotiabank

By

-- Risk appetite is "on the run" to start the fresh trading week, said Derek Holt, Vice-President & Head of Capital Markets Economics, at Scotiabank in his 'Daily Points' note Monday.

Holt noted oil was up by 5%-6% a barrel, while United States equity futures were down by about 0.5%, with European equities down by about double that amount.

He also noted the US dollar (USD) was slightly firmer against most majors except for the Canadian dollar (CAD or loonie) and Norway's krone (NOK), while sovereign bond yields were up by around 2bps to 6bps across regions and maturities, with Europe underperforming U.S. Treasuries.

On geopolitics, Holt said U.S. President Donald Trump appears to have "grossly overstated" progress toward an agreement with Iran on Friday.

Other than that there was, he added, very light calendar-based risk through the overnight. German producer prices soared in March (+2.5% m/m, consensus 1.4%). China left the 1- and 5-year Loan Prime Rates unchanged at 3% and 3.5% respectively which surprised no one.

Related Articles

Asia

Ora Banda Mining Appoints Chair-elect

Ora Banda Mining (ASX:OBM) has appointed John Richards as chair-elect, with plans for him to assume the role following the retirement of current Chair Peter Mansell at the company's annual general meeting in November, according to a Tuesday filing with the Australian bourse.Richards is currently non-executive chair of Sandfire Resources (ASX:SFR) and lead independent non-executive director of Sheffield Resources (ASX:SFX), the filing added.

$ASX:OBM$ASX:SFR$ASX:SFX
Research

Research Alert: Universal Health Services: Q1 Eps Tops Estimates

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:UHS delivered solid Q1 results, with adjusted EPS of $5.62 (up 16.1% Y/Y), $0.16 above consensus, while revenue grew 9.6% to $4.495B due to higher prices despite modest patient volumes. Same-facility acute care revenue increased 8.2% on flat adjusted admissions but 6.3% growth in revenue per admission, while behavioral health saw 1.2% admission growth and 7.3% revenue growth. We think the $835M Talkspace acquisition may expand UHS's virtual behavioral health capabilities and broaden payor mix. Management expects the deal to close in Q3. Operating cash flow improved 11.7% to $402M, and UHS repurchased $127.3M in stock, though adjusted EBITDA margin compressed 20 bps to 14.4% on higher operating expenses. We think behavioral health staffing challenges persist but expect the Talkspace integration to create growth opportunities.

$UHS
Research

Research Alert: Cls Q1: Blistering Fy 26 Guidance And Cpo Win Tempered By Capital Demands

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Q1 revenues of $4.05B (+53%) and adjusted EPS of $2.16 (+80%) both exceeded guidance on accelerating hyperscaler demand. Adjusted operating margin reached a record 8.0%, due to higher-value CCS offerings, which grew 76% to $3.24B, with segment margin expanding to 8.6%. The company secured a new CPO switch program with a hyperscaler customer expected to ramp in 2027, and we expect more color tomorrow. Management raised 2026 guidance to $19.0B revenue (from $17.0B) and $10.15 adjusted EPS (from $8.75), representing over $6.5B in revenue growth. Stronger growth is anticipated for 2027 based on improved customer visibility and new program wins. The company enlarged its balance sheet by upsizing its credit facility to $2.5B, with revolver capacity increased to $1.75B. FCF of $137.9M remained robust despite elevated capex of $218.4M to support capacity expansion. Share buybacks slowing, FCF guidance lagging, and a +50% month may be contributing to the after-hours selloff.

$CLS